EN-CV
03 Nisan 2026

Full Name: Prof. Dr. Oğuz KARABAY

Title: Professor

Department: Infectious Diseases and Clinical Microbiology

Foreign Language: English

EDUCATION
  • Trakya University Faculty of Medicine (Medicine)
  • Trakya University Faculty of Medicine, Infectious Diseases (Residency)
WORK EXPERIENCE
  • Sakarya University Faculty of Medicine (2011 - Present)
  • Sakarya Training and Research Hospital (2008-2011)
  • Abant İzzet Baysal University Faculty of Medicine (2003-2008)
  • Düzce SSK Hospital (1999-2003)
  • Mareşal Çakmak Military Hospital (1998-1999)
  • Trakya University Faculty of Medicine (1993-1997)
SPECIALTIES
  • Infection Control
  • Antimicrobial Resistance and Multidrug-Resistant Infections
  • Viral Diseases (Hepatitis, HIV, COVID-19)
CERTIFICATES
  • Good Clinical Practice
  • Hospital Infections Training Certificate
  • Advanced Statistics Training Certificate
  • Occupational Medicine Training Certificate
  • Blood Transfusion Medicine Certificate
ACADEMIC AND SCIENTIFIC PUBLICATIONS
Publications Contributed as Researcher
  • Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine – New England Journal of Medicine (2020)
  • Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19 – New England Journal of Medicine (2022)
Publications as Author
  • INICC Report: 2010–2015 – American Journal of Infection Control (2016)
  • INICC Report: 2012–2017 – American Journal of Infection Control (2020)
  • The Spectrum of Diseases Causing Fever of Unknown Origin in Turkey – International Journal of Infectious Diseases (2008)
  • Comparison of Colistin Monotherapy and Combination Therapies in MDR Infections – Clinical Microbiology and Infection (2015)
  • Evaluation of Tularaemia Courses – Clinical Microbiology and Infection (2014)
  • Mortality Indicators in Pneumococcal Meningitis – Journal of Infection (2014)
  • West Nile Virus Infections in Turkey – Eurosurveillance (2012)
  • Acute Hepatitis B in Pregnancy Treatment – Hepatology Research (2013)
  • Staphylococcal Exotoxins Study – Otolaryngology–Head and Neck Surgery (2013)
  • Thymol Derivatives Study – Bioorganic Chemistry (2019)
  • Mycoplasma and Ureaplasma Study (2006)
  • Staphylococcus aureus ICU Study – American Journal of Infection Control (2013)
  • Spinal Brucellosis Treatment – Scottish Medical Journal (2020)
  • COVID-19 and Acute Kidney Injury – Journal of the College of Physicians and Surgeons Pakistan (2021)
  • HIV/AIDS Multicenter Study – TURK-HIV Study Group
  • Acinetobacter ICU Mortality Study – Mikrobiyoloji Bülteni (2012)
  • Escherichia coli Antibiotic Resistance – Journal of Chemotherapy